Which closed-end funds own Wuxi Biologics Cayman Inc?
2 active closed-end funds report this security in their latest N-PORT filing, with a combined reported value of $10.2M. Security type: common equity. Country: Cayman Islands. ISIN KYG970081173 · ticker 2269.HK.
Holdings are historical filings (report dates May 31, 2026 – Jun 30, 2026; N-PORT becomes public ~60 days after quarter end), not live positions. Weights are percent of each fund’s net assets. Different instruments of one issuer (shares, bonds, preferreds) are separate securities — see related securities below.
Funds holding this security
| Fund | Category | Weight | Value (USD) | Balance | Fund net assets | Prem/disc | Report date |
|---|---|---|---|---|---|---|---|
| EMF Templeton Emerging Markets Fund | International Equity | 1.25% | $5M | 1,175,078 sh | $403M | 9.3% discount | May 31, 2026 |
| BMEZ BlackRock Health Sciences Term Trust | Healthcare | 0.47% | $5.1M | 1,152,500 sh | $1.1B | NAV unavailable | Jun 30, 2026 |
2 positions. Source: SEC Form N-PORT via market-data vendor re-serve. Funds without an N-PORT on file cannot appear here.
Also listed in filings as: Wuxi Biologics Cayman, Inc..
Issuer-level search for “2269.HK” → · Compare two funds’ portfolios →